Diabetes insipidus epidemiology and demographics: Difference between revisions
| (3 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The [[prevalence]] of diabetes insipidus is estimated to be 3 | The [[prevalence]] of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide. The [[prevalence]] and [[incidence]] of both [[Central diabetes insipidus|central]] and [[Nephrogenic diabetes insipidus|nephrogenic DI]] does not vary by gender. Similarly, no significant racial predilection in [[prevalence]] has been observed. With both [[Central diabetes insipidus|central]] and [[Nephrogenic diabetes insipidus|nephrogenic diabetes inispidus]], inherited causes account for approximately 1-2% of all cases. The incidence of [[nephrogenic diabetes insipidus]] caused by [[Aquaporin 2|AQP2]] mutations is about 1 in 20 million births. | ||
With both [[Central diabetes insipidus|central]] and [[Nephrogenic diabetes insipidus|nephrogenic diabetes inispidus]], inherited causes account for approximately 1-2% of all cases. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The [[prevalence]] of diabetes insipidus is estimated to be 3 | The [[prevalence]] of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide.<ref name="pmid22248325">{{cite journal |vauthors=Verkman AS |title=Aquaporins in clinical medicine |journal=Annu. Rev. Med. |volume=63 |issue= |pages=303–16 |year=2012 |pmid=22248325 |pmc=3319404 |doi=10.1146/annurev-med-043010-193843 |url=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
| Line 23: | Line 21: | ||
===Gender=== | ===Gender=== | ||
The [[prevalence]] and [[incidence]] of both [[Central diabetes insipidus|central]] and [[nephrogenic diabetes insipidus]] does not vary by gender. | The [[prevalence]] and [[incidence]] of both [[Central diabetes insipidus|central]] and [[nephrogenic diabetes insipidus]] does not vary by gender.<ref name="pmid22248325" /> | ||
===Race=== | ===Race=== | ||
| Line 42: | Line 40: | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
Latest revision as of 21:16, 27 October 2017
|
Diabetes insipidus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diabetes insipidus epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Diabetes insipidus epidemiology and demographics |
|
Diabetes insipidus epidemiology and demographics in the news |
|
Risk calculators and risk factors for Diabetes insipidus epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
The prevalence of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide. The prevalence and incidence of both central and nephrogenic DI does not vary by gender. Similarly, no significant racial predilection in prevalence has been observed. With both central and nephrogenic diabetes inispidus, inherited causes account for approximately 1-2% of all cases. The incidence of nephrogenic diabetes insipidus caused by AQP2 mutations is about 1 in 20 million births.
Epidemiology and Demographics
Prevalence
The prevalence of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide.[1]
Incidence
The incidence of diabetes insipidus is 1 in 20 million births for nephrogenic diabetes insipidus caused by AQP2 mutations.[1]
Case Fatality Rate
The case-fatality rate of diabetes insipidus is unknown.
Age
Diabetes insipidus has been identified in all age groups from infancy to adulthood.
Gender
The prevalence and incidence of both central and nephrogenic diabetes insipidus does not vary by gender.[1]
Race
There is no racial predilection for diabetes insipidus.
Developed countries
Incidence, prevalence, and geographical distribution of both central diabetes insipidus and nephrogenic diabetes insipidus does not vary.
Developing countries
Incidence, prevalence, and geographical distribution of both central diabetes insipidus and nephrogenic diabetes insipidus does not vary.
References
- ↑ 1.0 1.1 1.2 Verkman AS (2012). "Aquaporins in clinical medicine". Annu. Rev. Med. 63: 303–16. doi:10.1146/annurev-med-043010-193843. PMC 3319404. PMID 22248325.